candesartan has been researched along with felodipine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rydén, L; Shimizu, M; Sjöquist, PO; Wang, QD | 2 |
| Anderson, A; Morgan, T | 1 |
| Böhm, M; Hilgers, S; Laufs, U; Nickenig, G; Wassmann, S | 1 |
| Böhm, M; Ghiassi, A; Nickenig, G; Wassmann, K; Wassmann, S | 1 |
| Tchernev, G | 1 |
1 review(s) available for candesartan and felodipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for candesartan and felodipine
| Article | Year |
|---|---|
A comparison of candesartan, felodipine, and their combination in the treatment of elderly patients with systolic hypertension.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Felodipine; Female; Humans; Hypertension; Male; Systole; Tetrazoles; Treatment Outcome | 2002 |
Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Cholesterol, LDL; Double-Blind Method; Endothelium, Vascular; Felodipine; Female; Forearm; Humans; Hypercholesterolemia; Inflammation; Male; Middle Aged; Prospective Studies; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Regional Blood Flow; Tetrazoles | 2002 |
AT1 receptor antagonism improves endothelial dysfunction in postmenopausal women.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Estrogens; Felodipine; Female; Forearm; Humans; Middle Aged; Plethysmography; Postmenopause; Prospective Studies; Tetrazoles; Treatment Outcome; Vasoconstrictor Agents | 2006 |
5 other study(ies) available for candesartan and felodipine
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury.
Topics: Angiotensin Receptor Antagonists; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Drug Therapy, Combination; Felodipine; Female; Hemodynamics; In Vitro Techniques; Indoles; Losartan; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Swine; Tetrazoles | 1999 |
Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs.
Topics: Anesthesia; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Antioxidants; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Coronary Disease; Drug Synergism; Drug Therapy, Combination; Evans Blue; Felodipine; Female; Hemodynamics; Indoles; Lipid Peroxidation; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Perfusion; Random Allocation; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Swine; Terphenyl Compounds; Tetrazoles | 1999 |
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Felodipine; Humans; Lisinopril; Melanoma; Metoprolol; Nitrosamines; Perindopril; Prospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors; Thiazides | 2023 |